Your browser is no longer supported. Please, upgrade your browser.
Settings
SNSS Sunesis Pharmaceuticals, Inc. daily Stock Chart
SNSS [NASD]
Sunesis Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own0.40% Shs Outstand75.45M Perf Week6.14%
Market Cap91.29M Forward P/E- EPS next Y-0.37 Insider Trans-61.83% Shs Float74.82M Perf Month-17.69%
Income-34.70M PEG- EPS next Q-0.13 Inst Own69.00% Short Float6.16% Perf Quarter-48.95%
Sales3.50M P/S26.08 EPS this Y-9.10% Inst Trans-2.63% Short Ratio2.01 Perf Half Y-45.25%
Book/sh0.24 P/B5.04 EPS next Y26.00% ROA-80.30% Target Price2.04 Perf Year-84.45%
Cash/sh0.52 P/C2.31 EPS next 5Y- ROE-269.30% 52W Range0.84 - 8.23 Perf YTD-52.55%
Dividend- P/FCF- EPS past 5Y42.80% ROI-195.20% 52W High-85.30% Beta2.03
Dividend %- Quick Ratio2.20 Sales past 5Y8.40% Gross Margin- 52W Low44.05% ATR0.20
Employees39 Current Ratio2.20 Sales Q/Q-55.00% Oper. Margin- RSI (14)39.25 Volatility8.94% 11.23%
OptionableYes Debt/Eq0.45 EPS Q/Q40.00% Profit Margin- Rel Volume0.44 Prev Close1.06
ShortableYes LT Debt/Eq0.26 EarningsJul 30 Payout- Avg Volume2.30M Price1.21
Recom3.00 SMA200.73% SMA50-45.12% SMA200-48.36% Volume1,016,672 Change14.15%
Jul-24-15Downgrade ROTH Capital Buy → Sell $5.50 → $1
Jul-24-15Downgrade Cantor Fitzgerald Buy → Hold
Jun-15-15Reiterated ROTH Capital Buy $4 → $5.50
May-05-15Reiterated ROTH Capital Buy $4.30 → $4
Dec-15-14Upgrade ROTH Capital Neutral → Buy $2.30 → $4.30
Dec-09-14Reiterated ROTH Capital Neutral $1.30 → $2.30
Oct-07-14Downgrade ROTH Capital Buy → Neutral $15 → $1.30
Oct-07-14Downgrade RBC Capital Mkts Outperform → Sector Perform $9 → $3
Jun-12-14Initiated UBS Buy $14
Sep-11-12Reiterated Cantor Fitzgerald Buy $6 → $8
May-29-12Upgrade RBC Capital Mkts Sector Perform → Outperform $3 → $5
Apr-13-12Initiated Cantor Fitzgerald Buy $6
Mar-06-12Initiated Canaccord Genuity Buy $4
Oct-11-11Downgrade RBC Capital Mkts Outperform → Sector Perform $4 → $3
Sep-29-11Initiated MLV Capital Buy $3.50
Aug-11-15 01:48PM  4 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet +6.40%
Aug-10-15 02:08PM  IBB claws its way back +15.74%
Aug-06-15 01:04PM  SUNESIS PHARMACEUTICALS INC Financials -6.77%
Aug-05-15 07:00AM  Sunesis Pharmaceuticals to Present at the 2015 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-04-15 04:01PM  Sunesis Announces Publication of Vosaroxin Phase 3 VALOR Trial Results in The Lancet Oncology GlobeNewswire
Aug-01-15 08:09PM  10-Q for Sunesis Pharmaceuticals, Inc. at Company Spotlight
Jul-30-15 08:02AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a +10.53%
07:46AM  Sunesis reports 2Q loss
07:00AM  Sunesis Pharmaceuticals Reports Second Quarter 2015 Financial Results and Recent Highlights GlobeNewswire
Jul-28-15 09:25AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 9.5% - Tale of the Tape +11.43%
Jul-27-15 12:00PM  GPM Announces Investigation of Sunesis Pharmaceuticals, Inc. Business Wire +9.49%
Jul-24-15 07:05PM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Sunesis Pharmaceuticals, Inc. Business Wire -72.36%
06:17PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Sunesis Pharmaceuticals, Inc. on Behalf of Investors Business Wire
02:23PM  Investigation of Sunesis Pharmaceuticals, Inc. Announced by The Law Offices of Howard G. Smith Business Wire
01:21PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Sunesis Pharmaceuticals, Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws Business Wire
11:38AM  Shareholder Alert: AF&T Announces That It Has Been Retained to Investigate Claims on Behalf of Investors in Sunesis Pharmaceuticals, Inc. Business Wire
09:45AM  Is This the End of Sunesis? at 24/7 Wall St.
08:45AM  Top Analyst Upgrades and Downgrades: Amazon, GM, SolarCity, Sunesis, United Continental, Disney, Valero and More at 24/7 Wall St.
07:39AM  Sunesis Pharma downgraded by ROTH Capital and Cantor Fitzgerald
Jul-23-15 06:11PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sunesis Pharmaceuticals, Inc. - SNSS Accesswire
05:37PM  Sunesis tumbles as FDA says it won't approve cancer drug
04:20PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:06PM  Sunesis Pharmaceuticals Announces Regulatory Update GlobeNewswire
Jul-22-15 03:30PM  Bristol-Myers' HIV-1 Inhibitor Gets Breakthrough Designation - Analyst Blog
Jul-21-15 06:31PM  BioMarin Provides Update on Phase II Talazoparib Study - Analyst Blog
05:00PM  Bristol-Myers' Opdivo Study Stopped Early, Meets Endpoint - Analyst Blog
Jul-20-15 11:08AM  Sunesis Pharmaceuticals, Inc. (SNSS) Shares March Higher, Can It Continue? - Tale of the Tape
Jul-02-15 09:32AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 8% - Tale of the Tape
Jul-01-15 07:00AM  Sunesis to Present at Cantor Fitzgerald's Inaugural Healthcare Conference GlobeNewswire +7.97%
Jun-23-15 09:25AM  Sunesis (SNSS) Worth Watching: Stock Moves 9.1% Higher - Tale of the Tape
Jun-19-15 07:35AM  Sunesis Pharmaceuticals (SNSS) Shares March Higher, Can It Continue? - Tale of the Tape
Jun-15-15 09:35AM  These Biotech Stocks Could Deliver Big Returns for Investors Accesswire
Jun-13-15 03:40AM  Edited Transcript of SNSS conference call or presentation 12-Jun-15 2:00pm GMT
Jun-12-15 03:08PM  How to Trade 5 of the Market's Most Active Stocks -- Buy, Hold or Sell? at TheStreet
11:25AM  Is Sunesis Coming Back From the Dead? at 24/7 Wall St.
10:00AM  Sunesis Pharmaceuticals, Inc. Presentations of VALOR Data Call scheduled for 10:00 am ET today
07:00AM  Sunesis Pharmaceuticals Presents New Data From VALOR Evaluating Vosaroxin in Older Patients With Acute Myeloid Leukemia at the 20th Congress of the European Hematology Association GlobeNewswire
Jun-10-15 04:04PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-31-15 09:00AM  Sunesis Pharmaceuticals Announces Presentation of VALOR Trial Subgroup Analysis at ASCO 2015 Annual Meeting GlobeNewswire
May-21-15 08:09AM  Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European Hematology Association GlobeNewswire
May-15-15 09:10AM  The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Update Marketwired +6.44%
May-14-15 07:00AM  Sunesis Pharmaceuticals Announces Presentation of VALOR Data at the 2015 ASCO Annual Meeting GlobeNewswire
May-13-15 07:00AM  Sunesis to Present at the 2015 UBS Global Health Care Conference GlobeNewswire +9.95%
May-07-15 08:09PM  10-Q for Sunesis Pharmaceuticals, Inc. at Company Spotlight
May-06-15 08:12PM  10-K for Sunesis Pharmaceuticals, Inc. at Company Spotlight
May-05-15 11:00AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today -7.83%
08:39AM  Sunesis reports 1Q loss
08:02AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
08:01AM  Sunesis Pharmaceuticals Reports First Quarter 2015 Financial Results and Recent Highlights at noodls
07:07AM  Q1 2015 Sunesis Pharmaceuticals Inc Earnings Release - Time Not Supplied
07:00AM  Sunesis Pharmaceuticals Reports First Quarter 2015 Financial Results and Recent Highlights GlobeNewswire
Apr-28-15 07:00AM  Sunesis to Host Conference Call on May 5th to Discuss First Quarter 2015 Financial Results and Recent Highlights GlobeNewswire
Apr-10-15 06:01AM  Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind at TheStreet
Apr-02-15 02:33PM  Sunesis Pharmaceuticals Inc.'s CEO Daniel Swisher Interviewed by The Life Sciences Report Marketwired
Mar-31-15 12:41PM  Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMeds Recent Activity in Biotech at Insider Monkey
Mar-24-15 02:13PM  4 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Mar-23-15 03:15PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Mar-12-15 04:48PM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and +6.42%
11:00AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today
08:11AM  Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights at noodls
07:27AM  Sunesis reports 4Q loss
07:07AM  Q4 2014 Sunesis Pharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights GlobeNewswire
Mar-05-15 01:42PM  3 Biotech stocks Under $10 to Trade for Breakouts at TheStreet +6.02%
07:00AM  Sunesis to Host Conference Call on March 12th to Discuss Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights GlobeNewswire
Mar-02-15 09:07AM  Sunesis Announces Amendment to Loan Agreement at noodls
07:00AM  Sunesis Announces Amendment to Loan Agreement GlobeNewswire
Feb-24-15 07:27AM  Sunesis to Present at Upcoming Investor Conferences at noodls
07:00AM  Sunesis to Present at Upcoming Investor Conferences GlobeNewswire
Feb-19-15 01:23PM  4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More at TheStreet
Feb-18-15 07:00AM  Sunesis to Present at the 2015 RBC Capital Markets' Global Healthcare Conference GlobeNewswire +7.17%
Feb-03-15 09:15AM  The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Panel Comments Marketwired
Jan-05-15 07:19PM  BTIG Initiates Coverage On Sunesis Pharmaceuticals, Believes Company 'Will Be Breakeven By 2017' Benzinga
Dec-16-14 01:04PM  SUNESIS PHARMACEUTICALS INC Financials EDGAR Online Financials +6.33%
Dec-09-14 01:30PM  Sunesis Pharmaceuticals Inc to Discuss Presentation of Phase 3 VALOR Trial Results at ASH Annual Meeting scheduled for 1:30 pm ET today CCBN
Dec-08-14 01:30PM  Sunesis Announces Presentation of Positive Updated Results from Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASH Annual Meeting GlobeNewswire
Dec-07-14 05:28PM  Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial at TheStreet
12:30PM  Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting GlobeNewswire
Dec-02-14 11:00AM  Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off at TheStreet
07:00AM  Sunesis Pharmaceuticals to Host Conference Call and Slide Webcast Tuesday, December 9 Following Presentation of Phase 3 VALOR Trial Results at ASH Annual Meeting GlobeNewswire
Nov-24-14 07:00AM  Sunesis Announces Publication of REVEAL-1 Trial Results in the British Journal of Haematology GlobeNewswire +6.60%
Nov-19-14 07:00AM  Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica GlobeNewswire
Nov-18-14 07:17AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% Zacks -10.39%
Nov-17-14 01:55PM  Is This the Sunesis Resurrection? at 24/7 Wall St. +38.32%
01:51PM  Sunesis Pharmaceuticals Bounces On Results Announcement at TheStreet
11:54AM  Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Data at TheStreet
09:05AM  Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual Meeting GlobeNewswire
Nov-12-14 07:09PM  10-Q for Sunesis Pharmaceuticals, Inc. Company Spotlight
Nov-10-14 10:30AM  Sunesis Pharmaceuticals Inc Earnings Call scheduled for 10:30 am ET today CCBN
08:02AM  SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
07:00AM  Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Nov-05-14 07:00AM  Sunesis to Present at Upcoming Investor Conferences GlobeNewswire
Nov-03-14 07:00AM  Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent Highlights GlobeNewswire
Oct-24-14 12:03PM  Ken Griffin has loaded up on Angie's List at MarketWatch +19.58%
Oct-22-14 12:23PM  Citadel Advisors adds to its position in Sunesis Pharmaceuticals Market Realist
Oct-15-14 08:29AM  Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% Zacks +7.83%
Oct-09-14 08:31AM  The Zacks Analyst Blog Highlights: Sunesis Pharmaceuticals, Chimerix, Regeneron and Incyte Zacks -13.29%
Oct-08-14 07:14AM  Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update Zacks +5.93%
Oct-07-14 04:19PM  Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth Benzinga -7.53%
03:40PM  Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo Zacks
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company is developing vosaroxin, an anti-cancer quinolone derivative for the treatment of acute myeloid leukemia (AML). It has completed a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML. The company also completed a Phase II single-agent trial of vosaroxin in platinum-resistant ovarian cancer. In addition, it is involved in the initiation of an investigator-sponsored trial of vosaroxin in combination with decitabine in older patients with untreated AML and high-risk myelodysplastic syndrome. Sunesis Pharmaceuticals, Inc. has a collaboration agreement with Biogen Idec to discover, develop, and commercialize small molecule inhibitors of the human protein Raf kinase; and licensing agreements with Millennium to provide worldwide license to develop and commercialize preclinical inhibitors of phosphoinositide-dependent kinase-1. The company was founded in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swisher Daniel N JRPresident and CEOAug 25Buy1.0112,21612,338199,736Aug 26 07:54 PM
Swisher Daniel N JRPresident and CEOAug 24Buy1.0112,78412,912187,520Aug 26 07:54 PM
Swisher Daniel N JRPresident and CEOJul 24Buy1.0225,00025,458174,336Jul 28 09:52 PM
BAY CITY CAPITAL LLC10% OwnerJul 24Sale3.46635,7022,199,5295,267,598Jul 28 06:32 PM
Ketchum Steven BDirectorJul 24Sale3.466,35821,98980,827Jul 28 09:53 PM
BJERKHOLT ERICEVP, CFO & Corp. SecretaryJul 24Sale3.466,35821,98980,395Jul 28 09:52 PM
Swisher Daniel N JRPresident and CEOJul 24Sale3.4612,71543,975142,869Jul 28 09:52 PM